These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 17110111)

  • 1. Anti-influenza virus activity of biflavonoids.
    Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
    Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
    Liu AL; Wang HD; Lee SM; Wang YT; Du GH
    Bioorg Med Chem; 2008 Aug; 16(15):7141-7. PubMed ID: 18640042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of potent sialidase-based inhibitors of influenza virus replication.
    von Itzstein M; Wu WY; Kok GB; Pegg MS; Dyason JC; Jin B; Van Phan T; Smythe ML; White HF; Oliver SW
    Nature; 1993 Jun; 363(6428):418-23. PubMed ID: 8502295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
    Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
    Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
    Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
    J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-influenza drugs: the development of sialidase inhibitors.
    von Itzstein M; Thomson R
    Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun C; Zhang X; Huang H; Zhou P
    Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral effect of strictinin on influenza virus replication.
    Saha RK; Takahashi T; Kurebayashi Y; Fukushima K; Minami A; Kinbara N; Ichitani M; Sagesaka YM; Suzuki T
    Antiviral Res; 2010 Oct; 88(1):10-8. PubMed ID: 20615432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
    Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
    J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.
    Ison MG; Gubareva LV; Atmar RL; Treanor J; Hayden FG
    J Infect Dis; 2006 Mar; 193(6):760-4. PubMed ID: 16479508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Function of neuraminidase of influenza virus and anti influenza compounds by its inhibition].
    Yamashita M
    Tanpakushitsu Kakusan Koso; 2009 Aug; 54(10):1284-91. PubMed ID: 19663256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Critical review of anti-influenza drugs].
    Claas EC; Kroes AC
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):635. PubMed ID: 10761554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
    Einecke D
    MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of sialidase activity as a therapeutic approach.
    Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
    Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
    Bianco A; Brufani M; Melchioni C
    Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procedure in V.a. influenza].
    Vogel VG
    MMW Fortschr Med; 2006 Jan; 148(4):60-1. PubMed ID: 16502803
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiviral activity of several vasodilator agents].
    Zhilinskaia IN; Platonov VG; Ashmarin IP; Kiselev OI
    Biull Eksp Biol Med; 1996 Feb; 121(2):167-9. PubMed ID: 9026122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.